Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicylic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis

Arthritis and Rheumatism

Volumn 42, Issue 9, 1999, Pages 1927-1935

  Volin, Michael V ^a   Harlow, Lisa A ^a   Woods, James M ^a   Campbell, Phillip L ^a   Amin, M Asif ^a   Tokuhira, Michihide ^a   Koch, Alisa E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MESALAZINE; MONOCYTE CHEMOTACTIC PROTEIN 1; SALAZOSULFAPYRIDINE; SULFAPYRIDINE;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BIOCOMPATIBLE MATERIALS; CELL DIVISION; CHEMOKINE CCL2; CHEMOTAXIS; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-8; LAMININ; MESALAMINE; PROTEOGLYCANS; SOLUBILITY; SULFAPYRIDINE; SULFASALAZINE;

EID: 0033502949     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199909)42:9<1927::AID-ANR19>3.0.CO;2-X     Document Type: Article

References (45)

1. Svartz N. Salazopyrin, a new sulfanilimide preparation. Acta Medica Scand 1942;110 Suppl:577-98.
2. Schroder H, Campbell DE. Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther 1972;13: 539-51.
3. Farr M, Brodrick A, Bacon PA. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis. Rheumatol Int 1985;5:247-51.
4. Bird HA. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid: which is the active moiety in rheumatoid arthritis? Br J Rheumatol 1995;34 Suppl 2:16-9.
5. Pullar T, Hunter JA, Capell HA. Which component of sulphasalazine is active in rheumatoid arthritis? BMJ 1985;290:1535-8.
6. Szekanecz Z, Szegedi G, Koch AE. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Invest Med 1998; 46:27-41.
7. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995;376:517-9.
8. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-801.
9. Olson JA, Whitelaw CM, McHardy KC, Pearson DW, Forrester JV. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 1997;40:1166-71.
10. Gadangi P, Longaker M, Naime D, Levin RI, Recht PA, Montesinos MC, et al. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol 1996;156:1937-41.
11. Aono H, Hasunuma T, Fujisawa K, Nakajima T, Yamamoto K, Mita S, et al. Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and hucillamine. J Rheumatol 1996;23:65-70.
12. Nose M, Sasano M, Kawashima Y. Salazosulfapyridine suppresses chondrocyte mediated degradation induced by interleukin 1β. J Rheumatol 1997;24:550-4.
13. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993;156:235-46.
14. Kinsella JL, Grant DS, Weeks BS, Kleinman HK. Protein kinase C regulates endothelial cell tube formation on basement membrane matrix, Matrigel. Exp Cell Res 1992;199:56-62.
15. Gately S, Twardowski P, Stack MS, Patrick M, Boggio L, Cundiff DL, et al. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res 1996;56:4887-90.
16. Szekanecz Z, Shah MR, Pearce WH, Koch AE. Increased intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells. Clin Exp Immunol 1994;98:337-43.
17. Goebeler M, Yoshimura T, Toksoy A, Ritter U, Brocker EB, Gillitzer R. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol 1997;108:445-51.
18. Koch AE, Kunkel SL, Harlow LA. Johnson B, Evanoff HL, Haines GK, et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992;90:772-9.
19. Koch AE, Kunkel SL, Shah MR. Hosaka S, Halloran MM, Haines GK, et al. Growth-related gene product alpha: a chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995; 155:3660-6.
20. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, et al. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 1994;94:1012-8.
21. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in C-X-C chemokine-mediated angiogenesis. J Biol Chem 1995;270:27348-57.
22. Hirata S, Matsubara T, Saura R, Tateishi H, Hirohata K. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum 1989;32:1065-73.
23. Firestein GS, Paine MM, Boyle DL. Mechanisms of methotrexate action in rheumatoid arthritis: selective decrease in synovial collagenase gene expression. Arthritis Rheum 1994;37:193-200.
24. Haynes WL, Proia AD, Klintworth GK. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci 1989;30:1588-93.
25. Silverman KJ, Lund DP, Zetter BR, Lainey LL, Shahood JA, Freiman DG, et al. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 1988;153:347-52.
26. Koch AE, Cho M, Burrows J, Leibovich SJ, Polverini PJ. Inhibition of production of macrophage-derived angiogenic activity by the anti-rheumatic agents gold sodium thiomalate and auranofin. Biochem Biophys Res Commun 1988;154:205-12.
27. Saura R, Matsubara T, Mizuno K. Inhibition of neovascularization in vivo by gold compounds. Rheumatol Int 1994;14:1-7.
28. Bull DA, Seftor EA, Hendrix MJ, Larson DF, Hunter GC, Putnam CW. Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. J Surg Res 1993;55: 473-9.
29. Madhok R, Wijelath E, Smith J, Watson J, Sturrock RD, Capell HA. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization? J Rheumatol 1991;18:199-202.
30. Sharon P, Drab EA, Linder JS. Weidman SW, Sabesin SM, Rubin DB. The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution: comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine. J Lab Clin Med 1992;119:99-107.
31. Sexl V, Mancusi G, Baumgartner-Parzer S, Schutz W, Freissmuth M. Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Br J Pharmacol 1995;114:1577-86.
32. Kria L, Ohira A, Amemiya T. TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia. Curr Eye Res 1998;17:986-93.
33. Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, et al. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 1990;20:2141-4.
34. Deleuran B, Kristensen M, Paludan K, Zachariae C, Larsen CG, Zachariae E, et al. The effect of second-line antirheumatic drugs on interleukin-8 mRNA synthesis and protein secretion in human endothelial cells. Cytokine 1992;4:403-9.
35. Koch AE, Shah MR, Harlow LA, Lovis RM, Pope RM. Soluble intercellular adhesion molecule-1 in arthritis. Clin Immunol Immunopathol 1994;71:208-15.
36. Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol 1997;36:164-9.
37. Blann AD, Herrick A, Jayson MI. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol 1995;34:814-9.
38. Pooley N, Ghosh L, Sharon P. Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis. Dig Dis Sci 1995;40:219-25.
39. Veale DJ, Maple C, Kirk G, McLaren M, Belch JJ. Soluble cell adhesion molecules-P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol 1998;27:296-9.
40. Bouma MG, van den Wildenberg FA, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 1996;270:C522-9.
41. Wahl C, Liptay S, Adler G. Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998;101:1163-74.
42. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene: cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 1997;272:31092-9.
43. Voraberger G, Schafer R, Strtowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region: induction by cytokines and phorbol ester. J Immunol 1991;147:2777-86.
44. Mukaida N, Mahe Y, Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 1990;265:21128-33.
45. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994;10:405-55.